Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg

Long description

Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg

Short description

Kyleena, 19.5 mg

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

S Non-covered by Medicare statute

BETOS category

P6C Minor procedures - other (Medicare fee schedule)

Cross reference

J7296

Added

July 1, 2017

Last change

January 1, 2018 – No change

Termination date

December 31, 2017

Nearby Q codes

• Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
• Q9977 – Compounded drug, not otherwise classified
• Q9978 – Netupitant 300 mg and palonosetron 0.5 mg
• Q9979 – Injection, alemtuzumab, 1 mg
• Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
• Q9981 – Rolapitant, oral, 1 mg
• Q9982 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
• Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
• Q9985 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• Q9986 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
• Q9987 – Pathogen(s) test for platelets
• Q9988 – Platelets, pheresis, pathogen-reduced, each unit
• Q9989 – Ustekinumab, for intravenous injection, 1 mg
• Q9991 – Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
• Q9992 – Injection, buprenorphine extended-release (sublocade), greater than 100 mg
• Q9993 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg